We are live on ! Find out more
VANI icon

Vivani Medical
VANI

42 hedge funds and large institutions have $5.87M invested in Vivani Medical in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.02% less ownership

Funds ownership: 0.26% → 0.25% (-0.02%)

6% less capital invested

Capital invested by funds: $6.26M → $5.87M (-$388K)

7% less funds holding

Funds holding: 45 → 42 (-3)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
42
Holders Change
-3
Holders Change %
-6.67%
% of All Funds
0.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
5
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$32.7K
2
LPL Financial
LPL Financial
California
+$18.3K
3
Lido Advisors
Lido Advisors
California
+$10.3K
4
TRCT
Tower Research Capital (TRC)
New York
+$9.25K
5
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$2.99K

Top Sellers

Rank Fund Capital Flow
1
PVH
Psagot Value Holdings
Israel
-$247K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$133K
3
BlackRock
BlackRock
New York
-$49.5K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$20K
5
Millennium Management
Millennium Management
New York
-$13K

VANI Hedge Fund Activity: Q2 2019 in Review

42 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2019, worth a combined $5.87M — down 6.2% from $6.26M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of VANI and 4 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 5 added.

The largest buyer was Geode Capital Management, adding an estimated $32.7K. The largest seller was Psagot Value Holdings, exiting entirely with an estimated $247K sold.

  • 42 institutional investors held Vivani Medical (VANI) as of Q2 2019, down from 45 in Q1 2019.
  • Funds reported $5.87M of Vivani Medical stock for Q2 2019, down 6.2% quarter-over-quarter.
  • 4 funds opened new Vivani Medical positions in Q2 2019 and 7 closed out, a net change of -3 holders.
  • The largest Vivani Medical buyer in Q2 2019 was Geode Capital Management, an estimated $32.7K added.
  • The largest Vivani Medical seller in Q2 2019 was Psagot Value Holdings, an estimated $247K sold.

Based on aggregated 13F filings for Q2 2019.